Format

Send to

Choose Destination
Nat Rev Cancer. 2005 Jun;5(6):459-67.

Immunotherapy for pancreatic cancer - science driving clinical progress.

Author information

1
Department of Medical Oncology, Room G89, Baltimore, Maryland 21231-1000, USA.

Abstract

The identification of key signalling pathways involved in immune-system regulation, along with the development of early pancreatic tumours in mouse models have provided new opportunities for pancreatic cancer treatment and prevention. Immunotherapy for pancreatic cancer is one approach that is at a crucial crossroads, as therapeutics that are designed to target pancreatic-cancer-associated antigens and regulatory signalling molecules are entering clinical trials.

PMID:
15905855
DOI:
10.1038/nrc1630
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center